ClinicalTrials.govpublic full text
Impact of Empagliflozin on Functional Capacity in Heart Failure with Preserved Ejection Fraction
heart failure with preserved ejection fraction, heart failure, diastolic, diabetes mellitus, exercise, invasive exercise testing, sglt-2 inhibitors, interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 825826
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.